Ixazomib citrate (MLN9708) is a prodrug of Ixazomib (MLN-2238) and an orally bioavailable second-generation proteasome inhibitor with an IC50 of 3.4 nM, exhibiting potential antineoplastic activity.
Molecular Weight:
517.12
Purity:
98.37%
CAS Number:
[1239908-20-3]
Formula:
C20H23BCl2N2O9
Target:
Autophagy|||Proteasome
T8397
* VAT and and shipping costs not included. Errors and price changes excepted